Work

MammaTrace – a tumor naïve cell-free DNA methylation test for minimal residual disease in breast cancer

Year: 2026

Type: article

Abstract: Methylation sequencing data used to develop MammaTrace – a tumor naïve cell-free DNA methylation test for minimal residual disease in breast cancer.

Source: Zenodo (CERN European Organization for Nuclear Research)

DOI: 10.5281/zenodo.21349211

Authors: Buckley, David N, Kalfa, Alex J, Gooden, Gerald, Lewinger, Juan Pablo, Pacheco, Marissa, Gayton, Jessica, Spicer, Darcy, Carpten, John, Stewart, Daphne, Lenz, Heinz-Josef, Hughes Halbert, Chanita, Lerman, Caryn, O'Shaughnessy, Joyce, Pockaj, Barbara, Bodour, Salhia

Institutions: University of Southern California, Mayo Clinic in Arizona, Mayo Clinic Hospital, City Of Hope National Medical Center, Baylor University Medical Center

Language: English

Topic: Cancer Genomics and Diagnostics

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W7169125697

FWCI:

Cites:

Cited by:

Related to: 10